Sixth Industry Standing Group (ISG) meeting, from 21/09/2023 to 21/09/2023

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Zentiva, emtricitabine,tenofovir disoproxil, HIV Infections, Date of authorisation: 09/11/2016, Revision: 8, Status: Authorised

Enpr-EMA newsletter 2022

Valproate: Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s) - EMEA/H/N/PSR/J/0036

Valproate : List of nationally authorised medicinal products - EMEA/H/N/PSR/J/0036

Valproate : PRAC non-interventional imposed PASS final study report assessment report - EMEA/H/N/PSR/J/0036

Human medicines European public assessment report (EPAR): Pradaxa, dabigatran etexilate, Arthroplasty, Replacement;Venous Thromboembolism, Date of authorisation: 17/03/2008, Revision: 40, Status: Authorised

COVID-19 vaccines: key facts

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Hemorrhagic Fever, Ebola, Date of authorisation: 01/07/2020, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Mvabea, Ebola vaccine (MVA-BN-Filo [recombinant]), Hemorrhagic Fever, Ebola, Date of authorisation: 01/07/2020, Revision: 4, Status: Authorised